# Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

> **NCT01044303** · PHASE4 · COMPLETED · sponsor: **East Carolina University** · enrollment: 32 (actual)

## Conditions studied

- Transplant; Failure, Kidney

## Interventions

- **DRUG:** Myfortic Escalation

## Key facts

- **NCT ID:** NCT01044303
- **Lead sponsor:** East Carolina University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01044303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01044303, "Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01044303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*